心血管病学进展2024,Vol.45Issue(3) :211-215.DOI:10.16806/j.cnki.issn.1004-3934.2024.03.005

经皮去肾神经术:最新证据与患者筛选

Percutaneous Renal Denervation:Latest Evidence and Patient Selection

李悦 卢成志
心血管病学进展2024,Vol.45Issue(3) :211-215.DOI:10.16806/j.cnki.issn.1004-3934.2024.03.005

经皮去肾神经术:最新证据与患者筛选

Percutaneous Renal Denervation:Latest Evidence and Patient Selection

李悦 1卢成志1
扫码查看

作者信息

  • 1. 天津市第一中心医院心内科,天津 300000
  • 折叠

摘要

尽管有许多药物和非药物治疗可降低血压,但难治性高血压仍是一个重要的健康问题.经皮去肾神经术(RDN)已成为有发展前景、临床证据最多的用于改善血压、提高血压控制率的器械治疗方法.现总结目前RDN治疗高血压的机制,同时总结关于RDN的多项随机假手术对照的临床研究和优化患者选择.

Abstract

Despite the existence of numerous pharmacological and non-pharmacological interventions for lowering blood pressure,refractory hypertension persists as a significant health concern.Renal denervation(RDN)has become a promising and clinically proven instrument therapy method for improving blood pressure and increasing blood pressure control.This review summarizes the current understanding of the mechanisms behind RDN in treating hypertension and provides an overview of several randomized sham-controlled clinical studies on RDN,as well as optimization of patient selection.

关键词

高血压/交感神经系统/去肾神经术

Key words

Hypertension/Sympathetic nervous system/Renal denervation

引用本文复制引用

出版年

2024
心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
参考文献量31
段落导航相关论文